Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Autoimmunity is Scopus-indexed (Q2, CiteScore 7), WoS SCIE, DOAJ. Published by Taylor and Francis Ltd..
Checked against the index lists dated .
ISSN 0891-6934Verify ISSN ↗1607-842XVerify ISSN ↗
Publisher: Taylor and Francis Ltd.
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Immunology and Allergy | 69 / 234 | 70th | Q2 |
| Immunology | 77 / 243 | 68th | Q2 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 1988–present, best quartile Q2, CiteScore 7.
Autoimmunity is Q2 in Immunology and Allergy (rank 69 of 234) and Q2 in Immunology (rank 77 of 243), by CiteScore 2025.
Autoimmunity is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 7, which places it in quartile Q2 at the 70th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.035, quartile Q2, with an H-index of 87.
Autoimmunity is published by Taylor and Francis Ltd. Its print ISSN is 0891-6934 and its online ISSN is 1607-842X.
Yes — indexed in the Science Citation Index Expanded.
Yes — it is an open-access journal, listed in DOAJ.
Autoimmunity has an h-index of 98 and a 2-year mean of 4.44 citations per paper (OpenAlex). Its Scopus CiteScore is 7, quartile Q2. On 2-year citations it ranks #47 of 231 Scopus journals in Immunology and Allergy.
Autoimmunity published 32 papers in 2025; its busiest recent year was 2021 with 63. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 98 research articles (2024–2026), authors are most often from China (65.5%), United States (13.1%) and Germany (2.9%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 6 retracted papers are recorded (2 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.